Traws Pharma, Inc. (TRAW) — DEF 14A Filings
All DEF 14A filings from Traws Pharma, Inc.. Browse 4 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (4)
-
Traws Pharma Sets Virtual 2025 Annual Meeting, Key Compensation Votes Ahead
— Oct 8, 2025 Risk: low
Traws Pharma, Inc. (TRAW) is holding its 2025 Annual Meeting of Stockholders on November 21, 2025, virtually, to address several key proposals. Shareholders wil -
Traws Pharma Files 2025 Proxy Statement
— Feb 6, 2025 Risk: low
Traws Pharma, Inc. (formerly Onconova Therapeutics, Inc.) filed a Definitive Proxy Statement (DEF 14A) on February 6, 2025, for the fiscal year ending December -
Traws Pharma Files Definitive Proxy Statement
— Oct 11, 2024 Risk: low
Traws Pharma, Inc. (formerly Onconova Therapeutics, Inc.) filed a Definitive Proxy Statement (DEF 14A) on October 11, 2024, for its fiscal year ending December -
Traws Pharma Files Amended Proxy Statement
— Aug 9, 2024 Risk: low
Traws Pharma, Inc. (formerly Onconova Therapeutics, Inc.) filed an amended DEF 14A proxy statement on August 9, 2024, for its annual meeting on September 16, 20
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX